HMB for Muscle Preservation During GLP-1 Weight Loss: What the Evidence Actually Says

As an Amazon Associate, sci-supplements.com earns from qualifying purchases. Links in this article may be affiliate links.

GLP-1 medications preserve less muscle than people assume – and more than they fear. HMB (beta-hydroxy beta-methylbutyrate) has emerged as one of the more specific supplement recommendations for this exact problem. Here’s what the evidence actually supports.

Why muscle preservation became a GLP-1 conversation

Across GLP-1 receptor agonist trials, a meaningful share of total weight lost – commonly cited around 25-40% – comes from lean mass rather than fat. A 2026 study using detailed body-composition and muscle-function measurements in both mice and a small human pilot found that while absolute muscle size decreased modestly, relative muscle strength was largely preserved, and fat loss was still preferentially targeted over lean tissue. The takeaway from current research is nuanced: some lean mass loss is real and expected, but it appears to be a proportionate side effect of significant weight loss generally, not a uniquely dangerous GLP-1 side effect – and it is still worth actively managing.

What HMB actually is and its evidence base

HMB is a metabolite of the amino acid leucine, studied for decades primarily in older adults, clinical populations, and people at risk of muscle wasting. A systematic review of randomized controlled trials found an overall positive, though modest, effect on muscle mass and strength at the most commonly studied dose of 3.0g/day, including in populations dealing with significant muscle loss such as cancer patients. This is a different and generally more vulnerable population than the average person using a GLP-1 medication for weight loss, which matters for how directly the evidence translates.

The case for HMB specifically alongside GLP-1 use

The mechanistic logic is sound: HMB is best studied precisely in situations of caloric restriction and reduced anabolic drive, which is exactly the metabolic context GLP-1 medications create. That said, there are not yet dedicated randomized trials testing HMB specifically in GLP-1 users – the current recommendation is an extrapolation from HMB’s broader muscle-preservation evidence rather than a GLP-1-specific trial finding.

What matters more than any supplement

Across the GLP-1 and body composition research, the two interventions with the clearest, most consistent support for preserving muscle are resistance training and adequate protein intake – both outperform any single supplement in the evidence base. HMB is reasonably viewed as a secondary addition on top of these fundamentals, not a substitute for them.

Dosing used in trials

Most positive trials use 3g/day of HMB (as calcium HMB or the free-acid form), typically split into 2-3 doses across the day.

FAQ

Has HMB been tested specifically in people taking GLP-1 medications?
Not yet in dedicated randomized trials – current recommendations extrapolate from HMB’s broader evidence in muscle preservation during caloric restriction.

Is HMB more effective than just eating more protein?
Protein intake and resistance training have the stronger, more consistent evidence base; HMB is better positioned as an addition to these than a replacement.

Do GLP-1 medications definitely cause dangerous muscle loss?
Recent detailed studies suggest relative muscle strength is largely preserved despite some reduction in absolute muscle size – the picture is more reassuring than early concerns suggested, though muscle preservation strategies remain worthwhile.

Sources

• 2026 study on GLP-1 medicines, muscle mass, and function in mice and humans: PubMed
• Systematic review of HMB supplementation on muscle mass and function: PMC

This article is for educational purposes and is not medical advice. Talk to your prescribing doctor about muscle-preservation strategies alongside GLP-1 treatment.